This trial is studying a combination of atezolizumab and cobimetinib to treat patients with non-small cell lung cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Non-Small Cell Lung Cancer
- Stage IV Non-small Cell Lung Cancer
1 Primary · 6 Secondary · Reporting Duration: Up to 90 days
1 Treatment Group
Treatment (atezolizumab, cobimetinib)
1 of 1
48 Total Participants · 1 Treatment Group
Primary Treatment: Atezolizumab · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has the FDA granted authorization for Atezolizumab?
"There is existing clinical data that attests to the safety of Atezolizumab, so it was accorded a score of 2." - Anonymous Online Contributor
How many facilities are involved in the administration of this experiment?
"The clinical trial is recruiting from the University of Oklahoma Health Sciences Center in Oklahoma City, Wake Forest University at Clemmons in North Carolina and Moffitt Cancer Centre in Tampa Bay. Additionally, there are an additional 9 medical sites participating." - Anonymous Online Contributor
How many individuals are receiving treatment as part of this clinical experiment?
"Affirmative. According to information stored on clinicaltrials.gov, this medical trial is actively accepting enrolment. Originally posted in July of 2018 and last updated on November of 2022, the research requires 24 individuals across 9 sites." - Anonymous Online Contributor
What disease processes can be treated with Atezolizumab?
"Atezolizumab is a commonly prescribed medication to combat certain cases of small cell lung cancer. It may also be used as treatment for metastatic melanoma, unresectable melanoma and other malignant neoplasms." - Anonymous Online Contributor
Is recruitment still underway for this experiment?
"Based on the clinicaltrials.gov website, this medical trial is still recruiting patients and was initially posted in July 2018 before being updated last November." - Anonymous Online Contributor
Has there been previous research conducted on Atezolizumab?
"In 2008, the first trials of atezolizumab began taking place in SCRI Tennessee Oncology Chattanooga. At this time, there have been 101 completed studies and 374 ongoing ones across different locations - particularly Oklahoma City, Oklahoma." - Anonymous Online Contributor
Is this a pioneering endeavor in clinical trials?
"Since 2008, Atezolizumab has been the subject of various medical studies. After its initial Phase 1 trial funded by Hoffmann-La Roche in 2008 involving 720 participants, it received approval for a Phase 2 drug trial and is now being researched across 74 countries with 374 active clinical trials occurring in 1651 cities." - Anonymous Online Contributor